Literature DB >> 8436897

Mortality among injecting drug users: a critical reappraisal.

M Frischer1, M Bloor, D Goldberg, J Clark, S Green, N McKeganey.   

Abstract

STUDY
OBJECTIVE: The aim was to quantify all cause mortality among injecting drug users.
DESIGN: This was a retrospective analysis of 1989 data on injecting drug users and mortality obtained from three independent agencies: the Procurator Fiscal's Office, the General Register Office, and the Scottish HIV-test register.
SETTING: Greater Glasgow, Scotland.
SUBJECTS: Drug injectors, estimated population 9424. MAIN
RESULTS: 81 names were found using the three sources to identify deaths. After removing duplicates, 51 deaths were found. This represented a mortality rate of 0.54% in the estimated population. Among female injectors the mortality rate was 0.85%, significantly higher than the rate of 0.42% among male injectors (95% CI for the true difference in mortality rates between female and male injectors was 0.31%-0.55%). Over 90% of deaths were attributed to overdose or suicide. Although AIDS caused only one death, 19% of cases (5/27) whose HIV antibody status could be ascertained were positive. The mortality rate among HIV positive injectors (3.8%) was significantly higher than among HIV negative injectors (0.49%).
CONCLUSIONS: Comprehensive coverage using three data sources revealed a far greater annual number of all cause deaths among injectors than would have been expected from previous research. The observed mortality rate was lower than in previous studies where the denominators used to calculate rates had an element of underenumeration. For the foreseeable future it is unlikely that AIDS will have much impact on mortality among injectors in Glasgow, because of the low prevalence of HIV infection among injectors in the city, and because HIV positive injectors are dying for reasons other than AIDS; rather, overdose and suicide will continue to be the main causes of death.

Entities:  

Mesh:

Year:  1993        PMID: 8436897      PMCID: PMC1059713          DOI: 10.1136/jech.47.1.59

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  8 in total

1.  Mortality and increasing drug use in Edinburgh: implications for HIV epidemic.

Authors:  C A Skidmore; J R Robertson; G Savage
Journal:  Scott Med J       Date:  1990-08       Impact factor: 0.729

2.  Adolescents, sex and injecting drug use: risks for HIV infection.

Authors:  M Barnard; N McKeganey
Journal:  AIDS Care       Date:  1990

3.  Estimated prevalence of injecting drug use in Glasgow.

Authors:  M Frischer
Journal:  Br J Addict       Date:  1992-02

4.  A new method of estimating prevalence of injecting drug use in an urban population: results from a Scottish city.

Authors:  M Frischer; M Bloor; A Finlay; D Goldberg; S Green; S Haw; N McKeganey; S Platt
Journal:  Int J Epidemiol       Date:  1991-12       Impact factor: 7.196

5.  Deaths of heroin users in a general practice population.

Authors:  A B Bucknall; J R Robertson
Journal:  J R Coll Gen Pract       Date:  1986-03

6.  Deaths of drug addicts in the United Kingdom 1967-81.

Authors:  A H Ghodse; M Sheehan; C Taylor; G Edwards
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-09

7.  Morbidity and mortality from heroin dependence. 1. Survey of heroin addicts known to home office.

Authors:  T H Bewley; O Ben-Arie; I P James
Journal:  Br Med J       Date:  1968-03-23

8.  Addict death rates during a four-year posttreatment follow-up.

Authors:  G W Joe; W Lehman; D D Simpson
Journal:  Am J Public Health       Date:  1982-07       Impact factor: 9.308

  8 in total
  18 in total

1.  Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999.

Authors:  K H Seal; A H Kral; L Gee; L D Moore; R N Bluthenthal; J Lorvick; B R Edlin
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

2.  Trends in young adult mortality in three European cities: Barcelona, Bologna and Munich, 1986-1995.

Authors:  C Borrell; M I Pasarín; E Cirera; P Klutke; E Pipitone; A Plasència
Journal:  J Epidemiol Community Health       Date:  2001-08       Impact factor: 3.710

3.  Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city.

Authors:  Susan G Sherman; Yingkai Cheng; Alexander H Kral
Journal:  Drug Alcohol Depend       Date:  2006-11-15       Impact factor: 4.492

4.  The relationship between lifetime abuse and suicidal ideation in a sample of injection drug users.

Authors:  Jacqueline J Lloyd; Erin P Ricketts; Jennifer R Havens; Llewellyn J Cornelius; David Bishai; Steven Huettner; Carl Latkin; Steffanie A Strathdee
Journal:  J Psychoactive Drugs       Date:  2007-06

5.  Fatal methadone and heroin overdoses: time trends in England and Wales.

Authors:  J Neeleman; M Farrell
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

Review 6.  Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.

Authors:  L Degenhardt; W Hall; M Warner-Smith
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

7.  A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO.

Authors:  Jonathan M Davis; Katie Suleta; Karen F Corsi; Robert E Booth
Journal:  AIDS Behav       Date:  2017-04

8.  Estimating the prevalence of drug misuse in Dundee, Scotland: an application of capture-recapture methods.

Authors:  G Hay; N McKeganey
Journal:  J Epidemiol Community Health       Date:  1996-08       Impact factor: 3.710

9.  Deprivation and mortality in Scotland, 1981 and 1991.

Authors:  P McLoone; F A Boddy
Journal:  BMJ       Date:  1994-12-03

10.  Opiates or cocaine: mortality from acute reactions in six major Spanish cities. State Information System on Drug Abuse (SEIT) Working Group.

Authors:  J Sánchez; B Rodríguez; L de la Fuente; G Barrio; J Vicente; J Roca; L Royuela
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.